Skip to main content
MedicineWatch US
Explore records
Trends
Coverage
About
Methodology
Report an issue
Privacy
Akcea Therapeutics, Inc.
Provisional
Carlsbad, CA · united states
1 recall flag(s), 1 Class I
FDA Flags (1)
Class I Recall
Jul 2022
Akcea Therapeutics, Inc.
Tegsedi (inotersen) Injection 284 mg/1.5 mL, Rx Only, Sterile solution for Subcutaneous Use, 4 prefilled syringes, each
Classification: Class I
Akcea Therapeutics, Inc. | MedicineWatch US